par Bellmunt, Joaquim;Négrier, Sylvie;Escudier, Bernard;Awada, Ahmad 
;Aapro, Matti;SIOG Taskforce,
Référence Critical reviews in oncology/hematology, 69, 1, page (64-72)
Publication Publié, 2009-01
;Aapro, Matti;SIOG Taskforce, Référence Critical reviews in oncology/hematology, 69, 1, page (64-72)
Publication Publié, 2009-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bellmunt, Joaquim; Négrier, Sylvie; Escudier, Bernard; Awada, Ahmad; Aapro, Matti; SIOG Taskforce, |
| Informations sur la publication: | Critical reviews in oncology/hematology, 69, 1, page (64-72) |
| Statut de publication: | Publié, 2009-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Bevacizumab |
| Elderly | |
| Interferon | |
| Metastatic renal cell cancer | |
| Sorafenib | |
| Sunitinib | |
| Temsirolimus | |
| MeSH keywords: | Adult |
| Aged | |
| Aged, 80 and over | |
| Antineoplastic Agents -- therapeutic use | |
| Carcinoma, Renal Cell -- drug therapy | |
| Carcinoma, Renal Cell -- secondary | |
| Clinical Trials, Phase III as Topic | |
| Humans | |
| Kidney Neoplasms -- drug therapy | |
| Middle Aged | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8428 |
| info:doi/10.1016/j.critrevonc.2008.08.002 | |
| info:pii/S1040-8428(08)00179-0 | |
| info:scp/56449118248 | |
| info:pmid/18774306 |
